CoChat
Sign Up
Cited by 479Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research Studies

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

Non–Small Cell Lung Cancer, Version 6.2015

Ettinger, David S., Wood, Douglas E., Akerley, Wallace, Bazhenova, Lyudmila A., Borghaei, Hossein, Camidge, David Ross, Cheney, Richard T., Chirieac, Lucian R., D’Amico, Thomas A., Demmy, Todd L., Dilling, Thomas J., Dobelbower, M. Chris, Govindan, Ramaswamy, Grannis, Frederic W., Horn, Leora, Jahan, Thierry M., Komaki, Ritsuko, Krug, Lee M., Lackner, Rudy P., Lanuti, Michael, Lilenbaum, Rogerio, Lin, Jules, Loo, Billy W., Martins, Renato, Otterson, Gregory A., Patel, Jyoti D., Pisters, Katherine M., Reckamp, Karen, Riely, Gregory J., Rohren, Eric, Schild, Steven E., Shapiro, Theresa A., Swanson, Scott J., Tauer, Kurt, Yang, Stephen C., Gregory, Kristina, Hughes, Miranda·2015·Journal of the National Comprehensive Cancer Network
DOI 10.6004/jnccn.2015.0071
Open this paper in CoChat — free account

Abstract

These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC). Appropriate targeted therapy is very effective in patients with advanced NSCLC who have specific genetic alterations. Therefore, it is important to test tumor tissue from patients with advanced NSCLC to determine whether they have genetic alterations that make them candidates for specific targeted therapies. These NCCN Guidelines Insights describe the different testing methods currently available for determining whether patients have genetic alterations in the 2 most commonly actionable genetic alterations, notably anaplastic lymphoma kinase (ALK) gene rearrangements and sensitizing epidermal growth factor receptor (EGFR) mutations.

Overview

Integrity signals

Registry

Crossref · 10.6004/jnccn.2015.0071

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 79 references

Cited by

Sorted by citations

See all 479

Related

Metadata

Authors
Ettinger, D. S., Wood, D. E., Akerley, W., Bazhenova, L. A., Borghaei, H., Camidge, D. R., Cheney, R. T., Chirieac, L. R., D’Amico, T. A., Demmy, T. L., Dilling, T. J., Dobelbower, M. C., Govindan, R., Grannis, F. W., Horn, L., Jahan, T. M., Komaki, R., Krug, L. M., Lackner, R. P., Lanuti, M., Lilenbaum, R., Lin, J., Loo, B. W., Martins, R., Otterson, G. A., Patel, J. D., Pisters, K. M., Reckamp, K., Riely, G. J., Rohren, E., Schild, S. E., Shapiro, T. A., Swanson, S. J., Tauer, K., Yang, S. C., Gregory, K., & Hughes, M.
Affiliations
  • The University of Texas MD Anderson Cancer Center (US)
  • Seattle Cancer Care Alliance (US)
  • Fox Chase Cancer Center (US)
  • Roswell Park Comprehensive Cancer Center (US)
  • Duke University (US)
  • City Of Hope National Medical Center (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • Northwestern University (US)
  • Mayo Clinic (US)
ORCID
Venue
Journal of the National Comprehensive Cancer Network
Publisher
Harborside Press, LLC
Published
2015-05
Volume
13
Issue
5
Pages
515-524
ISSN
  • 1540-1405 (ISSN-L)
  • 1540-1413
DOI
10.6004/jnccn.2015.0071
OpenAlex
W2000082608
Cited by
478
References
79
Citations by year
2026: 4 · 2025: 12 · 2024: 12 · 2023: 28 · 2022: 26 · 2021: 37 · 2020: 47 · 2019: 48 · 2018: 55 · 2017: 85 · 2016: 87 · 2015: 34
FWCI
68.82
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the National Comprehensive Cancer Network (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
Keywords
non-small cell lung cancer, targeted therapy, actionable genomic alterations, anaplastic lymphoma kinase rearrangement, EGFR mutation, advanced non-small cell lung cancer
MeSH terms
Carcinoma, Non-Small-Cell Lung, Genetic Testing, Humans, Lung Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review